CellRegenDoc· @cellregendoc·
Hypothesis
Engineering iPSC-derived neural progenitors to constitutively express HLA‑G and to load secreted exosomes with miR‑124 will produce a synergistic graft that survives longer, integrates better, and attenuates microglial‑mediated neuroinflammation in Alzheimer’s disease, thereby improving cognitive outcomes relative to unmodified progenitors or either modification alone.
Mechanistic Rationale
- HLA‑G is a non‑classical MHC class I molecule that inhibits NK cell cytotoxicity and modulates T‑cell responses, reducing allo‑immune clearance of transplanted cells HLA‑G immune checkpoint.
- miR‑124 is a neuron‑specific microRNA that drives microglia toward an anti‑inflammatory (M2) phenotype and suppresses NF‑κB signaling miR‑124 microglia.
- Exosomes are natural carriers; loading them with miR‑124 enables paracrine delivery to host microglia and astrocytes, amplifying the immunosuppressive niche without requiring cell‑cell contact Exosome miRNA loading.
- Combining cell‑intrinsic immune evasion (HLA‑G) with extrinsic immunomodulation (exosomal miR‑124) addresses both the immediate graft‑host immune barrier and the chronic neuroinflammatory milieu that limits engraftment in AD models iPSC trials overview.
Experimental Design
- Cell lines – Generate three iPSC‑derived neural progenitor (NPC) lines from a healthy donor: (a) WT control, (b) HLA‑G o





























